Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?

Objective. Comparing activity of 2 regimens combining oxaliplatin to bolus modulated fluorouracil as second line treatment in advanced pancreatic adenocarcinoma pretreated with gemcitabine-containing schedule. Methods. Forty eight patients with advanced pancreatic adenocarcinoma were randomly assign...

Descripción completa

Detalles Bibliográficos
Autores principales: Azmy, A., Abdelwahab, S., Yassen, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596913/
https://www.ncbi.nlm.nih.gov/pubmed/23533808
http://dx.doi.org/10.1155/2013/358538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596913/
https://www.ncbi.nlm.nih.gov/pubmed/23533808
http://dx.doi.org/10.1155/2013/358538

Ejemplares similares